[1]
“Dose Optimization of Sacubitril/Valsartan and Its Impact on Clinical Outcomes in Heart Failure with Reduced Ejection Fraction: A Systematic Review ”, JPS, vol. 9, no. 4, pp. 3203–3217, Oct. 2026, doi: 10.36490/journal-jps.com.v9i4.1898.